EFTRW

eFFECTOR Therapeutics, Inc. Warrant
EFTRW

Delisted

EFTRW was delisted on the 2nd of July, 2024.

Back to rankings

17 hedge funds and large institutions have $1.31M invested in eFFECTOR Therapeutics, Inc. Warrant in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$98K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$152K
2
+$25.4K
3
+$8.48K
4
ICM
III Capital Management
Florida
+$8.08K
5
UBS Group
UBS Group
Switzerland
+$1.15K

Top Sellers

1
-$59.9K
2
-$58K
3
-$42K
4
CH
CVI Holdings
Delaware
-$10.3K
5
WAM
Wolverine Asset Management
Illinois
-$7.36K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$634K
2
$175K
3
$140K
4
$128K
5
$63K
6
$35K
7
$24K
8
$23K
9
$16K
10
$14K
11
$14K
12
$13K
13
$12K
14
$10K
15
$6K
16
$4.3K
17
$1K
18
–
19
–